Triple Negative Breast Cancer Metastatic Clinical Trials
0 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.
Triple Negative Breast Cancer MetastaticMelanoma MetastaticColorectal Cancer Metastatic
Fudan University95 enrolled1 locationNCT06889610
Recruiting
Phase 2
Restoring Sensitivity To Immunotherapy In Advanced Triple Negative Breast Cancer Exploiting Ceralasertib Priming Followed By Combined Durvalumab/Nab-Paclitaxel
Triple Negative Breast Cancer Metastatic
IFOM ETS - The AIRC Institute of Molecular Oncology37 enrolled6 locationsNCT05582538